This is feeling a little silly. The vaccination rate in Africa is low... we shouldn't assume that this new variant is going to 100% get by the Vaccines. But there are ethical questions here... Just new vaccines all the time every year? Can our bodies handle that?
I THOUGHT YOU ALL WOULD LIKE TO KNOW MY ORIGIN STORY. I'm a little concerned about the pronouncing of my name- it's s-A-vant not savent...
Ourcall of the daycomes from Sven Henrich, founder of Northman Trader, who has been up early, scanning the charts and offering up the levels investors need to watch. And the winner, so to speak, for the S&P 500SPX,+0.23%is 4,550, the high for early September. “As long as this area holds bulls are fine as this could simply be a back test of the breakout,” he said in emailed comments. “A sustained move below and bulls are in big trouble, but if that area generally holds, then I suppose a end-of-year rally is still possible.” -Amazon's Black Friday greeted by climate activists, strikes in Europe * Climate activists target 13 Amazon depots in UK * Amazon says working to minimise potential customer disruption * Workers strike in Germany, France and Italy (Adds Amazon comment on potential disruption)
IRA IDEA*- LYB IF it's good enough for Steve Cohen.... LyondellBasell (LYB) Next up we have LyondellBasell, a global power in the chemical industry. This international company is the world’s largest player in the polyethylene and polypropylene technology space, owning the largest share of technologies and patents in the niche and profiting from licensing production. LYB also has a world-industry leading position in the production of polyolefin technologies, and has a large footprint in the more mundane refining of plastics and chemicals. This chemical company is facing a series of headwinds that bode ill for the near- to mid-term. Prices in the core segments of polyethylene and propylene are going down, while the natural gas the company uses for ethane feedstock is rising in cost. But there are bright points for investors. While EPS, at $5.25, missed the estimate of $5.78, revenues hit $12.69 billion in 3Q21, coming in above the $11.99 billion forecast, and amounting to the largest haul in the last two years, while growing 87% year-over-year. The company reported record cash flows from operations, at $2.1 billion, and used that to return ~$500 million to shareholders through dividends and share repurchases. The dividend is currently set at $1.13 per common share, for an annualized rate of $4.52 and a solid yield of ~5%. That yield is nearly triple the average dividend found among peer companies, or the return on Treasury bonds. Cohen, for his part, was impressed enough by this stock to purchase 136,101 shares. That’s a holding now worth $12.6 million. LyondellBasell shares have also caught the eye of JPMorgan analyst Jeffrey Zekauskaswho likes the company’s position via shareholder return potential. “Lyondell’s dividend yield is 5%, and its finances are remarkably strong: its net debt to EBITDA ratio is about 1.4x based on our estimates of year-end 2022 values. The company throws off 14-15% of its share price in free cash flow. We think that the dividend yield and the free cash flow yield should be supportive of the LYB share price. We think that the adverse trends are to a good degree already discounted into the Lyondell share price,” Zekauskas noted. To this end, Zekauskas rates LYB shares an Overweight (i.e. Buy) and has a $118 price target implying an upside of ~27% in the next 12 months
“It’s terrible news,” Ipek Ozkardeskaya, a senior analyst at Swissquote, said in emailed comments. “The new Covid variant could hit the economic recovery, but this time, the central banks won’t have enough margin to act. They can’t fight inflation and boost growth at the same time. They have to choose.”